Amine Belhabri

1.2k citations
40 papers · 458 indexed · h-index 14
Topics
Acute Myeloid Leukemia Research (22 papers)Chronic Myeloid Leukemia Treatments (8 papers)Lymphoma Diagnosis and Treatment (7 papers)
Partner nations
FranceBelgiumNetherlands

In The Last Decade

Amine Belhabri

34 papers receiving 451 citations

Peers

Amine Belhabri
Comparison fields: 5 of 64
  • Hematology 272
  • Molecular Biology 147
  • Genetics 112
  • Oncology 95
  • Public Health, Environmental and Occupational Health 92
Replace Carla Filì with:
Carla Filì Italy
Rayaz Ahmed India
Masatoshi Sakurai Japan
Margaret M. Showel United States
Eiji Usui Japan
Motohiro Tsuzuki Japan
Silvia Manfroi Italy
D.C. Setubal Brazil
Keiren Kirkland United Kingdom
R. Pasold Germany
Amine Belhabri relative to Carla Filì Italy Carla Filì's profile →
Citations per field
00.5×1.5×2.1×
Carla Filì · 1×
Citations per year

Countries citing papers authored by Amine Belhabri

Since Specialization
Citations

This map shows the geographic impact of Amine Belhabri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amine Belhabri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amine Belhabri more than expected).

Fields of papers citing papers by Amine Belhabri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amine Belhabri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amine Belhabri. The network helps show where Amine Belhabri may publish in the future.

Co-authorship network of co-authors of Amine Belhabri

This figure shows the co-authorship network connecting the top 25 collaborators of Amine Belhabri. A scholar is included among the top collaborators of Amine Belhabri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amine Belhabri. Amine Belhabri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 7
4 2
5 1
6 0
7 42
8 26
9 63
10 22
11 52
12 31
13
Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial
2
14 28
15
Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial
5
16 16
17 5
18 27
19 14
20 13

About Amine Belhabri

Amine Belhabri is a scholar working on Hematology, Genetics and Oncology, having authored 40 papers that have together received 458 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Hematology (272 citations), Genetics (112 citations) and Pathology and Forensic Medicine (65 citations). Amine Belhabri has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Norbert Vey, D Fière, Philippe A. Cassier, Marie Castets, Xavier Thomas, Mauricette Michallet, E Archimbaud, C Charrin, Jean‐Pierre Magaud and Bruno Anglaret. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026